Location: Zunyi
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Zunyi
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis Phase 2 · Zunyi Medical College - No.1 Affiliated Hospital · Eli Lilly and Company · NCT07415044 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer Phase 1/Phase 2 · The Second Affiliated Hospital of Zunyi Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367516 China HeadAche DIsorders RegiStry Phase N/A · The First People's Hospital of Zunyi · Beijing Tiantan Hospital · NCT05334927 Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicent Phase N/A · Affiliated Hospital of Zunyi Medical University · Shanghai Pulmonary Hospital, Shanghai, China · NCT07243873 The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management NA · Research Site · AstraZeneca · NCT06909773 Real-world Study of Aflibercept 8 mg in nAMD Phase N/A · Affiliated Hospital Of Zunyi Medical University · Peking University People's Hospital · NCT07640997 A Study of MI078 for Postpartum Depression Phase 3 · Affiliated Hospital of Zunyi Medical University · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Che Phase 3 · Affiliated Hospital of Zunyi Medical Universityl · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07165951 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo Phase 3 · The Second Affiliated Hospital Of Zunyi Medical University · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) Phase 3 · Wuchuan Gelao and Miao Autonomous County Hospital of Traditi · Beijing Tiantan Hospital · NCT06157502 eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Phase 3 · Research Site · AstraZeneca · NCT05952557 CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention Phase 4 · Affiliated Hospital of Zunyi Medical University · Zunyi Medical College · NCT06283888 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema Phase 3 · Zunyi Medical University Affiliated Hospital · Bio-Thera Solutions · NCT07515079 Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia Phase 2/Phase 3 · The Second Affiliated Hospital of Zunyi Medical University · Beijing Continent Pharmaceutical Co, Ltd. · NCT07388680 Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV) NA · Zunyi Medical University Affiliated Hospital · Harbin Medical University · NCT07567625 A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma Phase 3 · Research Site · AstraZeneca · NCT06471257 A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus Phase 2 · The Affiliated Hospital of Zunyi Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07509892 To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome Phase 3 · The Affiliated Hospital of Zunyi Medical University · Staidson (Beijing) Biopharmaceuticals Co., Ltd · NCT07208591 POASAC Study (Preoperative Anemia Severity and Classification Study) Phase N/A · Department of Anesthesiology, Affiliated Hospital of Zunyi M · Peking Union Medical College Hospital · NCT06499974 Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at Hig Phase 3 · Affiliated Hospital Of Zunyi Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT05862337 The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatri Phase 3 · The First People's Hospital of Zunyi · Oupushifang Pharmaceutical Technology Co., Ltd. · NCT06708156 Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer NA · Affiliated Hospital of Zunyi Medical University · Sun Yat-sen University · NCT02966483 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD Phase 3 · Affiliated Hospital of Zunyi Medical University · Hoffmann-La Roche · NCT05878769 Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis NA · Zunyi Medical University Affiliated Hospital, Guizhou Provin · West China Second University Hospital · NCT07431060 A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography Phase N/A · The Second Affiliated Hospital of Zunyi Medical University · First Hospital of China Medical University · NCT07133516 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function Phase 3 · Research Site · AstraZeneca · NCT06307652 A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR20 Phase 3 · The Affiliated Hospital of Zunyi Medical University · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT06635798 Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) Phase 2/Phase 3 · Affiliated Hospital of Zunyi Medical University · Huashan Hospital · NCT05401071 Lung Health of Early COPD: A Multi-center Cohort Study Phase N/A · Affiliated Hospital of Zunyi Medical University · Ting YANG · NCT05466396
Look up another city
Look up another condition